<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(11)</volume><submitter>Hegi ME</submitter><journal>Neuro-oncology</journal><pagination>1425-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4648310</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?</pubmed_title><pmcid>PMC4648310</pmcid><pubmed_authors>Stupp R</pubmed_authors><pubmed_authors>Hegi ME</pubmed_authors></additional><is_claimable>false</is_claimable><name>Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?</name><description/><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2025-04-26T19:25:26.418Z</modification><creation>2025-04-06T16:04:49.369Z</creation></dates><accession>S-EPMC4648310</accession><cross_references><pubmed>26374690</pubmed><doi>10.1093/neuonc/nov198</doi></cross_references></HashMap>